News & Press: Latest News

MDMA Statement on the “STRONGER Patents Act”

Wednesday, June 21, 2017  
Share |

MDMA Statement on the “STRONGER Patents Act”

Washington, D.C. – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding introduction of the “STRONGER Patents Act” in the United States Senate:

MDMA applauds the bipartisan work of Senators Chris Coons, Tom Cotton, Dick Durbin and Mazie Hirono for devising legislation that thwarts frivolous patent lawsuits while leveling the playing field for inventors.  The ‘STRONGER Patents Act’ provides a balanced, targeted approach to end abuse, support innovation and spur the lifesaving cures and therapies that patients and providers desperately need.

“MDMA has always supported targeted efforts to deal with patent litigation abuse, and the ‘STRONGER Patents Act’ will address this problem while not having the unintended consequences of weakening one's intellectual property rights.  We look forward to working with Congress and all policy makers to help ensure that America's innovation ecosystem remains the envy of the world.”